Answers are grounded in this paper and cite their sources.
Research demonstrates binding differences of non-neutralizing antibodies to transferrin receptor 1 in vitro, suggesting implications for pathogen inhibition.
The human transferrin receptor 1 (TfR1), regulates iron uptake into cells by binding the iron carrier, transferrin (Tf). It is also a target for various mammalian pathogens that target its apical domain, away from the Tf binding site. This underscores the opportunity to target TfR1 as a novel strategy to develop broadly neutralizing therapeutics. A myriad of antibodies have been developed against TfR1 for a variety of purposes that stem from cancer treatment to imaging tools. A subsection of these antibodies are referred to as “non-neutralizing,” meaning they do not impede binding of transferrin, and also prevent binding of certain pathogens. Typically, these end up being antibodies that bind at the apical domain and while the rough epitopes are known, more detailed binding mechanisms of these antibodies have yet to be determined. Currently, there are 6 antibodies that have been shown to either block binding of NWM pathogens and/or malarial parasite Plasmodium vivax receptor binding protein 1: OKT9, 128.1, T56/14, MEM-189, 23D10, and 13E4. I aim to assay these antibodies for binding to TfR1 at neutral and low pH’s, their specificity using animal constructs of the apical domain, and their ability to prevent binding of NWM pseudoviruses. All to answer the question whether there are meaningful differences in how they prevent pathogen entry, their selectivity, and if those differences can be explained through the structure. It was shown that these antibodies have differing affinity for either TfR1 or AP01, pH dependencies, species specificity, and ability to inhibit JUNV/MACV pseudovirus internalization via ELISA. In conjunction with determined cryoEM high-resolution structures of OKT9, 128.1, and 13E4 Fab bound to TfR1, it elucidates their unique binding mechanisms and properties.
No takes yet. Share an insight, caveat, or question.
Munoz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: